Laddar...
Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients
BACKGROUND: Myeloid-derived suppressor cells (MDSC) and M2 monocytes/macrophages are two types of suppressive myeloid antigen presenting cells that have been shown to promote tumor progression and correlate with poor prognosis in cancer patients. Tumor antigen specific monoclonal antibodies (mAb) ha...
Sparad:
| I publikationen: | J Immunother Cancer |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4647471/ https://ncbi.nlm.nih.gov/pubmed/26579227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-015-0097-6 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|